This new principle called ‘monocomponent chemoembolization’ showed the first good results in routine intra-arterial chemoembolization of oral cancer patients and will be continued.

Lenvatinib (LEN) is a first-line therapy for patients with advanced hepatocellular carcinoma (HCC); however, it has shown modest survival benefits. Therefore, we aimed to compare clinical outcomes of ...

NEW YORK (Medscape Wire) May 22 -- Chemoembolization should be the standard approach in selected patients with unresectable hepatocellular carcinoma, based on improved survival in a randomized ...

Neil Osterweil Nov. 6, 2002 (Boston) — When surgery is not an option for treatment of hepatocellular carcinoma, arterial chemoembolization, but not tamoxifen, may prolong survival of patients ...

As an alternative to surgery, percutaneous or laparoscopic radio frequency ablation or alcohol injection may be used as curative therapy for early HCC. For unresectable HCC that is unsuitable for ...

Combining transarterial chemoembolization (TACE) with lenvatinib (Lenvima) as first-line treatment for advanced hepatocellular carcinoma (HCC) prolonged survival compared with lenvatinib alone ...

According to this report Global Transarterial Chemoembolization (TACE) Market will rise from Covid-19 crisis at moderate growth rate during 2021 to 2028. Transarterial Chemoembolization (TACE) Market ...